CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer
暂无分享,去创建一个
Wenchuan Wu | D. Jin | W. Lou | Dansong Wang | T. Kuang | Xue-feng Xu | H. Yin | Jian-ang Li | N. Pu | Guo-chao Zhao | Abulimiti Nuerxiati | Guochao Zhao
[1] Wenchuan Wu,et al. Neutralizing TGF-β promotes anti-tumor immunity of dendritic cells against pancreatic cancer by regulating T lymphocytes , 2018, Central-European journal of immunology.
[2] Lianfang Zheng,et al. PD-1/PD-L1 and immunotherapy for pancreatic cancer. , 2017, Cancer letters.
[3] Manish B. Patel,et al. Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX , 2017, Expert review of clinical pharmacology.
[4] K. Hirakawa,et al. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1+ to CD8+ Lymphocyte Ratio in Patients with Colorectal Cancer. , 2017, Anticancer research.
[5] D. Busch,et al. Cytomegalovirus vector expressing RAE‐1γ induces enhanced anti‐tumor capacity of murine CD8+ T cells , 2017, European journal of immunology.
[6] A. Zaniboni,et al. Immunotherapy for pancreatic cancer: present and future. , 2017, Immunotherapy.
[7] X. Bai,et al. [Advances in immunotherapy of pancreatic ductal adenocarcinoma]. , 2017, Zhonghua wai ke za zhi [Chinese journal of surgery].
[8] Nicolai J. Birkbak,et al. Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors , 2017, Immunity.
[9] E. Munck‐Wikland,et al. Validation of Human Papillomavirus as a Favourable Prognostic Marker and Analysis of CD8+ Tumour-infiltrating Lymphocytes and Other Biomarkers in Cancer of Unknown Primary in the Head and Neck Region. , 2017, Anticancer research.
[10] Z. Ahmad,et al. Building a better understanding of the burden of disease in familial chylomicronemia syndrome , 2017, Expert review of clinical pharmacology.
[11] R. Xu,et al. The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance , 2017, Journal of clinical medicine.
[12] Yufeng Zou,et al. Interleukin-12 activated CD8+ T cells induces apoptosis in breast cancer cells and reduces tumor growth. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[13] Xuefang Li,et al. A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy. , 2016, Journal of theoretical biology.
[14] D. Sandnes,et al. The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migration , 2016, Journal of experimental & clinical cancer research : CR.
[15] J. Taube,et al. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy , 2016, Nature Reviews Cancer.
[16] E. Jaffee,et al. TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner , 2015, Oncotarget.
[17] C. Drake,et al. Immune checkpoint blockade: a common denominator approach to cancer therapy. , 2015, Cancer cell.
[18] Lixin Wei,et al. TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization , 2015, Cellular Physiology and Biochemistry.
[19] S. Leung,et al. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration , 2014, Breast Cancer Research.
[20] Donghui Li,et al. Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer , 2014, PloS one.
[21] E. Raymond,et al. Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas , 2013, Oncotarget.
[22] Hongtao Zhang,et al. Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancers. , 2013, Experimental and molecular pathology.
[23] J. Ahn,et al. Prognostic impact of FOXP3 expression in triple-negative breast cancer , 2013, Acta oncologica.
[24] A. DeMichele,et al. CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients , 2012, Science Translational Medicine.
[25] R. deLeeuw,et al. The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature , 2012, Clinical Cancer Research.
[26] R. McLendon,et al. Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans. , 2011, Blood.
[27] E. Ranieri,et al. TGF-β promotes immune suppression by inhibiting Treg cell apoptosis. , 2010, Immunotherapy.
[28] E. Ranieri,et al. Role of cytotoxic CD4+ T cells in cancer immunotherapy. , 2010, Immunotherapy.
[29] Kohei Miyazono,et al. TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.
[30] K. Ohkusu-Tsukada,et al. Targeted inhibition of IL‐10‐secreting CD25− Treg via p38 MAPK suppression in cancer immunotherapy , 2010, European journal of immunology.
[31] Y. Setiady,et al. In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti‐CD25 monoclonal antibody is mediated by FcγRIII+ phagocytes , 2010, European journal of immunology.
[32] J. Barkun,et al. Long-term immunosuppression with anti-CD25 monoclonal antibodies in heart transplant patients with chronic kidney disease. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[33] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[34] Wenchuan Wu,et al. Survival prediction in pancreatic cancer patients with no distant metastasis: a large-scale population-based estimate. , 2018, Future Oncology.
[35] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[36] Wenchuan Wu,et al. Low intratumoral regulatory T cells and high peritumoral CD8+ T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy , 2015, Cancer Immunology, Immunotherapy.